Development and characterization of a novel human CD137 agonistic antibody with anti-tumor activity and a good safety profile in non-human primates

Development and characterization of a novel human CD137 agonistic antibody with anti-tumor activity and a good safety profile in non-human primates

Author: Yingying Gao,Teddy Yang,Hu Liu,Ningning Song,Chaohui Dai,Yu Ding

Citation: Gao, Y., Yang, T., Liu, H. et al. Development and characterization of a novel human CD137 agonistic antibody with anti-tumor activity and a good safety profile in non-human primates. FEBS Open Bio. (2022). https://doi.org/10.1002/2211-5463.13494

Used in this study: B-h4-1BB Mice

Read entire article

Share:

Back to top